BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs4950928
,
SIRT1
,
Angiogenesis
,
Pseudomonas infection
,
Lung
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Trinucleotide repeat expansion
Summary
General Info
Curated Studies
Most Correlated Studies
CAG-repeat RNA-based toxicity in Drosophila
Corneal endothelium of Fuchs' endothelial corneal dystrophy patients
Peripheral whole blood from patients with spinocerebellar ataxia type-12
Cardiomyocytes derived from iPSCs of type 1/2 myotonic dystrophy subjects
Friedreich’s ataxia induced pluripotent stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Trinucleotide repeat expansions catalyzed by human cell-free extracts.
The 26S proteasome drives trinucleotide repeat expansions.
Msh2-Msh3 interferes with Okazaki fragment processing to promote trinucleotide repeat expansions.
Histone deacetylase complexes promote trinucleotide repeat expansions.
Instability and chromatin structure of expanded trinucleotide repeats.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in …
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
A Trial of Metformin in Individuals With Fragile X Syndrome
Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy
Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ